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Cellular expression of angiotensin type I receptor mRNA in the kidney.
Angiotensin II has multiple renal effects that are important in the
regulation of renal hemodynamics and electrolyte secretion, and bind-
ing sites for angiotensin II have been demonstrated in different cells of
the kidney. In the present study the cellular localization of mRNA for
the angiotensin type I (AT1) subtype of the angiotensin II receptor was
studied in adult rat kidney using a cRNA probe and in Situ hybridiza.
tion. Strong labeling was demonstrated in tubule cells of the inner and
outer stripe of the outer medulla. In emulsion-dipped sections, counter-
stained with hematoxylin-eosin, labeling was identified in segment S3 of
proximal tubules and in the thick ascending limb of loop of Henle
(mTAL). The results suggest expression of AT1-receptor mRNA with a
distinct compartmentalization within the nephron.
Angiotensin II is an octapeptide derived from the renin-
angiotensin system that regulates blood pressure and salt and
water metabolism via contraction of vascular smooth muscle
and stimulation of aldosterone secretion from the adrenal
cortex [1]. Specific angiotensin II receptors have been identified
on the cell surface of a large number of target tissues, including
vascular smooth muscle, adrenal, liver, lung, brain and kidney
[2]. Recent evidence suggests that there exist at least two
subtypes of angiotensin II receptors [3]. These subtypes,
termed AT1 and AT2, may be differentiated by their affinities for
the peptidergic ligand CGP 421 12A or the non-peptidergic
antagonist ligands DuP 753 and PD 123177. The AT1 receptor
has a high affinity for DuP 753 and a low affinity for PD 123177,
whereas the AT2 receptor has a high affinity for PD 123177 or
CGP 421 12A [4—6]. Furthermore, in the presence of the distil-
fide reducing agent dithiothreitol (DTT), the AT1 receptor
binding is greatly reduced, whereas the AT2 receptor binding
remains unchanged. The receptor subtypes operate via different
signal transductions pathways. The AT1 receptor appears to be
mainly coupled to a pertussis toxin-insensitive 0-protein which
stimulates phosphatidylinositol hydrolysis and mobilizes intra-
cellular Ca2 [7]. Activation of the AT2 receptor appears to
cause a decrease in cGMP levels [8, 9]. The AT1 receptor is
widely distributed and is the main receptor subtype responsible
for the cardiovascular and hemodynamic effects of angiotensin
II [101. The rat [11, 12], bovine [13] and human [14, 15] AT1
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receptor eDNA has been characterized, and the protein has
been shown to belong to the seven transmembrane family of
G-protein coupled receptors. More recently, the genomic orga-
nization of the AT1 receptor was also described [16]. A second
form of the AT1 receptor classified as AT18 has been cloned
from rat anterior pituitary tissue. It exhibits a 95%similarity in
amino acid sequence, the same binding of angiotensin II analogs
such as ATIA, and uses intracellular Ca2 as a second messen-
ger [17].
Angiotensin II binding sites have been found in the kidney
using radioligand binding techniques [18—20], and AT1 receptor
mRNA has been detected in the kidney by Northern blot
analysis and polymerase chain reaction (PCR) [12, 15, 21]. In
the present study we have by means of in situ hybridization
examined the cellular localization of angiotensin II subtype AT1
receptor mRNA in rat kidney.
Methods
RNA probe synthesis
The RNA probes were synthesized by in vitro transcription
from a 733 base pairs (bp) Eco RI/Kpn I rat AT 1 receptor
subtype-eDNA fragment, representing the positions 86-819 and
subcloned into the vector pGEM 3 (Promega, Madison, Wis-
consin, USA). For linearization of the plasmid Sty I was used.
Restriction with Sty I resulted in two different fragments. These
fragments were used for transcription with T 7 or SP 6 RNA
polymerase, respectively. The transcription with T 7 RNA
polymerase (Boehringer, Mannheim, Germany) resulted in a
353 nucleotide long cRNA, whereas a 380 nucleotide long
mRNA was obtained after in vitro transcription using SP 6 RNA
polymerase (Boehringer). The labelling was performed with
35S-a-UTP (NEN, Dupont, Boston, Massachusetts, USA). The
transcripts were purified using Nensorb (NEN) columns and
checked via denaturating formaldehyde gel electrophoresis.
The specificity of the probes was shown by RNase protection
assay [22].
In situ hybridization
Kidneys from male Sprague-Dawley rats (N = 4; body wt 200
g; ALAB, Stockholm, Sweden) who had free access to food
pellets and water were dissected out after rapid decapitation,
frozen on dry ice and sectioned at 14 m thickness in a cryostat
331
332 Meister et al: AT1-receptor mRNA in rat kidney
Fig. 1. Film autoradiograms of sections of
rat kidney after in situ hybridization with an
anti-sense (a) or sense (b) RNA probe to the
AT1-receptor. Strong hybridization signal can
be seen in the outer stripe and very strong
hybridization signal is observed in the inner
stripe of the outer medulla (OM), whereas the
outer part of the cortex (CO) and inner
medulla (IM) lack hybridization signal (a). In
a control section hybridized with a sense
RNA probe no labeling can be observed (b).
The photographs have been slightly retouched
with black paint in order to cover artifacts.
Bar = 1 mm.
(Dittes, Heidelberg, Germany) and thaw-mounted onto pre-
cleaned ProbeOnTM microscope slides (Fisher Biotech, Pitts-
burgh, Pennsylvania, USA). In situ hybridization was per-
formed as described previously [221. The slides were brought to
room temperature (RT) and fixed for 15 minutes in 4%
paraformaldehyde in phosphate buffered saline (PBS) pH 7.0.
After fixation the slides were washed in PBS for 10 minutes and
rinsed two times in sterilized water for five minutes each
followed by a deproteination of the tissue with 0.1 M HCI for 10
minutes. The slides were rinsed again 2x 3 mm each in PBS. To
decrease background the tissue was acetylated in 0.1 M trieth-
anolamine pH 8.0/0.25% acetic anhydride for 20 minutes,
washed again briefly in PBS, dehydrated in graded ethanol and
air dried. The slides were prehybridized in a humidified cham-
ber with 150 d prehybridization buffer (50% deionized forma-
mide, 50 mi Tris-HCI pH 7.6, 25 mis'i EDTA pH 8.0, 20 mM
NaC1, 0.25 mg/mI yeast tRNA, 2.5x Denhardt's solution
(0.05% Ficoll, 0.05% polyvinylpyrrolidone, 0.05% bovine se-
rum albumin) for two to four hours. After draining the prehy-
bridization buffer off the slides, the sections were hybridized
with 15 i1 hybridization buffer (50% deionized formamide, 20
mM Tris-HCI pH 7.6, 1 mM EDTA pH 8.0, 0.3 M NaCl, 0.2 M
DTT, 0.5 mg!ml yeast tRNA, 0.1 mg/mI poly-A-RNA, lx
Denhardt's solution, 10% dextransulfate) containing either 0.1
ng of the labeled cRNA or mRNA (sense probe) for control
experiments. The sections were covered with siliconized coy-
erslips and incubated at 37°C for 18 hours in a humidified
chamber. The coverslips were removed by washing with lx
standard saline citrate (SSC) at 48°C for 30 minutes, followed by
washing in 0.5 x SSC/50% formamide at 48°C for four hours and
changing the washing solution every hour. The slides were
rinsed 2x 10 mm in lx SSC, dehydrated through graded series
of alcohol, air dried and apposed to Hyperfilm-3H (Amersham
Ltd., Amersham, UK) at —20°C. After two months of expo-
sure, the films were developed with Kodak LX 24 for two
minutes and fixed for 15 minutes with Kodak AL 4. Some
sections were dipped in Kodak NTB2 emulsion, exposed for
two months at 20°C, and developed in Kodak D19 (4 mm) and
fixed in Kodak 3000 (10 mm). The slides were rinsed in distilled
water and coverslipped with glycerol. In addition, some of
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Fig. 2. Dark-field (a) and bright-field (b,c) photomicro graphs of emulsion-dipped sections and counter-staining with hematoxylin-eosin (b,c) of rat
kidney after in situ hybridization with a cRNA probe to the A T1-receptor. Silver grains can be seen overlying tubule cells in the inner and outer
stripe of the outer medulla (OM), whereas the cortex (CO) and inner medulla (IM) lack labeling (a). After counter-staining with hematoxylin-eosin,
silver grains are identified in proximal tubule cells in the outer stripe of the outer medulla (b) and in TAL cells in the inner stripe of the outer medulla
(c). Hatched line denotes kidney capsule. The photographs have been slightly retouched with black paint in order to cover artifacts. Bar = 100 m.
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these sections were counter-stained with hematoxylin-eosin,
dehydrated in graded series of ethanol and coverslipped with
Entellan® (Merck, Darmstadt, Germany). Eight sections per rat
were examined in a Nikon Microphot-FX microscope equipped
for bright-field and dark-field microscopy. Photographs were
taken with Kodak Tmax 100 ASA black and white film.
Results
In film autoradiograms, a strong hybridization signal could be
observed in the outer stripe and in the inner stripe of outer
medulla, with particularly intense labeling in the latter (Figs. la
and 2a). After emulsion dipping and counter-staining with
hematoxylin-eosin, it could be seen that silver grains were
overlying tubule cells in segment S3 of proximal tubules (Fig.
2b) and in the medullary part of the thick ascending limb (TAL)
of loop of Henle (Fig. 2c). There was no labeling in tubule cells
of the cortex, in the inner medulla, in glomeruli or in renal
vessels (Figs. la and 2a). Mter addition of 0.1 ng of mRNA
(sense RNA) to the hybridization mixture no signal could be
detected (Fig. ib).
Discussion
Using angiotensin II receptor subtype selective antagonists it
has been shown that the predominant subtype of angiotensin II
receptor in the kidney is of the AT1 subtype [20, 231. In
agreement, Northern blot analysis and PCR techniques have
revealed presence of AT1 receptor mRNA in the kidney [12, 15,
21]. The present results demonstrate that AT1 receptor mRNA
is expressed in segment S3 of proximal tubule cells and in the
mTAL cells in the outer medulla. Our findings are of substantial
interest, since increasing evidence suggests that angiotensin II
controls renal sodium excretion, not only by affecting renal
hemodynamics and aldosterone secretion, but also via a direct
effect on renal epithelial sodium transport [24-26]. The effect on
sodium reabsorption seems to be biphasic, since 10— 13 to b_b
M leads to stimulation of proximal tubule reabsorption, while
M inhibits proximal fluid reabsorption [27, 28]. Saralasin
and converting enzyme inhibitors have previously been shown
to induce natriuresis in normal animals and in humans [29—32],
and inhibition of sodium transport in the whole proximal tubule
has been reported for both saralasin and captopril [29, 33, 34].
The presence of AT1 receptor mRNA in proximal tubules is also
interesting, since the AT1 receptor antagonist DuP 753 has been
shown to inhibit bicarbonate and NaCl transport in segment Si
of proximal convoluted tubules of the rat [35]. However, in this
study we found no AT1 receptor mRNA in the Si segment, but
only in the S3 segment. The above-mentioned effect is most
likely the result of decreased intracellular levels of cAMP and a
subsequent increase in Na/H antiporter activity [36—38].
These results have indicated that endogenous angiotensin II
may play a role in the tonic support of proximal tubule cell
function, and that DuP 753 markedly inhibits solute and water
absorption and may be used for the treatment of hypertension
[35].
Angiotensin converting enzyme also exists in high amounts in
proximal tubule cells and in the outer medulla, with a progres-
sive increase in activity from the Sl to the S3 segment, and
higher concentrations in brush border membranes as compared
to apical membranes [39—42]. Interestingly, there appears to
exist a local renal production of angiotensin II, since angioten-
sinogen mRNA has been demonstrated by in situ hybridization
in the proximal tubule [43], and its expression is increased by
sodium depletion and androgen administration [44, 45]. Thus,
these epithelial cells may regulate their own ability to cause
Na reabsorption by forming and releasing angiotensin pep-
tides.
Angiotensin II has multiple renal effects that are of impor-
tance for the regulation of renal hemodynamics and electrolyte
secretion [46]. These actions include, for example, contraction
of glomerular mesangial cells [47], renal vascular vasoconstric-
tion [48] and effects on sodium reabsorption in proximal tubule
cells [28]. Radioligand binding and autoradiography have been
used to demonstrate angiotensin II binding sites on glomeruli
and glomerular mesangial cells [20, 23, 47, 49—53], renal vessels
[54], in the outer medulla [18, 20], and in both basolateral and
apical membranes of proximal tubule cells [19, 20, 51, 52,
55—57]. In contrast to glomerular angiotensin II receptors, the
proximal tubule receptor density is increased with sodium
depletion and decreased with sodium loading or mineralocorti-
coid administration [51]. Several of the above-mentioned stud-
ies suggest the presence of angiotensin II receptors on glomeruli
and glomerular mesangial cells. Furthermore, in cultured rat
glomerular mesangial cells the gene expression of the AT1
receptor is down-regulated by angiotensin II and cAMP [58]. In
the present study no labeling could be observed in glomeruli.
However, negative results obtained with the in situ hybridiza-
tion technique should be treated with caution, and the possibil-
ity that low levels of AT1 receptor mRNA are expressed at
these sites cannot be excluded. Nevertheless, the glomerular,
mesangial and vascular angiotensin receptors may be of a
particular AT1 subtype, that is, AT18 or an as yet undiscovered
subtype. Recently, a partial cDNA for a novel AT1® receptor
subtype was characterized from rat kidney [21]. Thus, the
angiotensin receptor in the inner part of the cortex and in the
mTAL may be of the ATIA subtype, whereas the glomerular
receptors may be of the AT1® subtype.
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